{"id":"NCT01455415","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain","officialTitle":"A Study Of Pregabalin In The Treatment Of Subjects With Painful Diabetic Peripheral Neuropathy With Background Treatment Of Nsaid For Other Pain Conditions","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2013-11","completion":"2013-12","firstPosted":"2011-10-20","resultsPosted":"2015-04-23","lastUpdate":"2021-01-28"},"enrollment":306,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Painful Diabetic Peripheral Neuropathy"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"1: Pregabalin","type":"EXPERIMENTAL"},{"label":"2: Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is to test the effectiveness of pregabalin in treating nerve pain caused by diabetes. The suitable subjects will be patients who also use an non-steroid anti-inflammatory drug for another pain which is not related to the diabetic nerve pain.","primaryOutcome":{"measure":"Average Diabetic Peripheral Neuropathy (DPN) Pain Based on a Numeric Rating Scale (NRS) Over the Last 7 Days of Each Treatment Period (Week 6 of Each Treatment Period)","timeFrame":"End of Period (includes both Visits 5 and 9)","effectByArm":[{"arm":"Pregabalin","deltaMin":4.98,"sd":0.127},{"arm":"Placebo","deltaMin":5.018,"sd":0.126}],"pValues":[{"comp":"OG000 vs OG001","p":"0.7174"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":61,"countries":["United States","Czechia","Italy","Sweden"]},"refs":{"pmids":["25968451"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081268&StudyName=Effect%20Of%20Pregabalin%20Treatment%20In%20Patients%20With%20Diabetic%20Nerve%20Pain%20Who%20Currently%20Use%20A%20Non-Steroid%20Anti-Inflammatory%20Drug%20%28NSAID%29%20For"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":272},"commonTop":["Dizziness","Somnolence","Diarrhoea","Fatigue","Oedema peripheral"]}}